✦ LIBER ✦

Phase II trial of recombinant interferon alfa-2 in the treatment of primary systemic amyloidosis

✍ Scribed by Dr. Morie A. Gertz; Robert A. Kyle

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 311 KB
Volume: 44
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830440210

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of α-tocopherol (vitamin

Phase II trial of α-tocopherol (vitamin E) in the treatment of primary systemic amyloidosis

✍ Dr. Morie A. Gertz; Robert A. Kyle 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB

Clinical phase II trial of recombinant d

Clinical phase II trial of recombinant dna interferon (interferon alfa 2b) in patients with metastatic malignant melanoma

✍ Thierry Dorval; Thao Palangie; Michel Jouve; Emilio Garcia-Giralt; Lucien Israel 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 2 views

A phase I-II trial of the combination of

A phase I-II trial of the combination of recombinant leukocyte a interferon and recombinant human interferon-γ in patients with metastatic malignant melanoma

✍ Edward T. Creagan; Charles L. Loprinzi; David L. Ahmann; Daniel J. Schaid 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 2 views

A phase II trial of 5-fluorouracil, leuc

A phase II trial of 5-fluorouracil, leucovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas

✍ Werner Scheithauer; Franz Pfeffel; Gabriela Kornek; Arthur Marczell; Christoph W 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB 👁 2 views

A Phase II trial of 5-fluorouracil and r

A Phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma

✍ Richard Pazdur; Jaffer A. Ajani; Rodger Winn; James Bearden; Robert J. Belt; Sus 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 2 views

A Phase I1 clinical trial of the combination of 5-fluorouracil (5-FU) and recombinant alpha-2a-interferon (a-2a-IFN) was conducted in 44 patients. Patients had not received chemotherapy previously and had measurable metastatic gastric carcinoma. 5-FU was administered as a continuous infusion at a do

Phase II clinical trial with 5-fluoroura

Phase II clinical trial with 5-fluorouracil, recombinant interferon-α-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus

✍ Scott Wadler; Hilda Haynes; Jonathan J. Beitler; Xiaoping Hu; Stanley Fell; Marg 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 1 views

## Background: Recombinant interferon-alpha (ifn) augments the cytotoxicity of both 5-fluorouracil (5-fu) and cisplatin in vitro. a phase ii study of 5-fu and ifn resulted in response rates of 25-27% in patients with metastatic esophageal carcinoma. ## Methods: A phase ii trial was initiated to d